Predicting P-glycoprotein substrates by a quantitative structure-activity relationship model

被引:89
|
作者
Gombar, VK [1 ]
Polli, JW [1 ]
Humphreys, JE [1 ]
Wring, SA [1 ]
Serabjit-Singh, CS [1 ]
机构
[1] GlaxoSmithKline, Preclin Drug Metab & Pharmacokinet, Res Triangle Pk, NC 27709 USA
关键词
absorption; blood-brain barrier; metabolism; multi-drug resistance; P-glycoprotein; QSAR; transporter;
D O I
10.1002/jps.20035
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A quantitative structure-activity relationship (QSAR) model has been developed to predict whether a given compound is a P-glycoprotein (Pgp) substrate or not. The training set consisted of 95 compounds classified as substrates or non-substrates based on the results from in vitro monolayer efflux assays. The two-group linear discriminant model uses 27 statistically significant, information-rich structure quantifiers to compute the probability of a given structure to be a Pgp substrate. Analysis of the descriptors revealed that the ability to partition into membranes, molecular bulk, and the counts and electrotopological values of certain isolated and bonded hydrides are important structural attributes of substrates. The model fits the data with sensitivity of 100% and specificity of 90.6% in the jackknifed cross-validation test. A prediction accuracy of 86.2% was obtained on a test set of 58 compounds. Examination of the eight "mispredicted" compounds revealed two distinct categories. Five mispredictions were explained by experimental limitations of the efflux assay; these compounds had high permeability and/or were inhibitors of calcein-AM transport. Three mispredictions Were due to limitations of the chemical space covered by the current model. The Pgp QSAR model provides an in silico screen to aid in compound selection and in vitro efflux assay prioritization. (C) 2004 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 93:957-968, 2004.
引用
收藏
页码:957 / 968
页数:12
相关论文
共 50 条
  • [1] Structure-activity relationship of P-glycoprotein substrates and modifiers
    Seelig, A
    Landwojtowicz, E
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 12 (01) : 31 - 40
  • [2] Structure-activity relationship: analyses of p-glycoprotein substrates and inhibitors
    Wang, RB
    Kuo, CL
    Lien, LL
    Lien, EJ
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2003, 28 (03) : 203 - 228
  • [3] Application of three-dimensional quantitative structure-activity relationships of P-glycoprotein inhibitors and substrates
    Ekins, S
    Kim, RB
    Leake, BF
    Dantzig, AH
    Schuetz, EG
    Lan, LB
    Yasuda, K
    Shepard, RL
    Winter, MA
    Schuetz, JD
    Wikel, JH
    Wrighton, SA
    MOLECULAR PHARMACOLOGY, 2002, 61 (05) : 974 - 981
  • [4] Cytocompatibility and P-glycoprotein Inhibition of Block Copolymers: Structure-Activity Relationship
    Cambon, A.
    Brea, J.
    Loza, M. I.
    Alvarez-Lorenzo, C.
    Concheiro, A.
    Barbosa, S.
    Taboada, P.
    Mosquera, V.
    MOLECULAR PHARMACEUTICS, 2013, 10 (08) : 3232 - 3241
  • [5] Structure-activity relationships for xenobiotic transport substrates and inhibitory ligands of P-glycoprotein
    Bain, LJ
    McLachlan, JB
    LeBlanc, GA
    ENVIRONMENTAL HEALTH PERSPECTIVES, 1997, 105 (08) : 812 - 818
  • [6] Three-dimensional quantitative structure-activity relationships of inhibitors of P-glycoprotein
    Ekins, S
    Kim, RB
    Leake, BF
    Dantzig, AH
    Schuetz, EG
    Lan, LB
    Yasuda, K
    Shepard, RL
    Winter, MA
    Schuetz, JD
    Wikel, JH
    Wrighton, SA
    MOLECULAR PHARMACOLOGY, 2002, 61 (05) : 964 - 973
  • [7] Progress in understanding the structure-activity relationships of P-glycoprotein
    Stouch, TR
    Gudmundsson, A
    ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (03) : 315 - 328
  • [8] Structure-activity relationship studies of propafenone analogs based on P-glycoprotein ATPase activity measurements
    Schmid, D
    Ecker, G
    Kopp, S
    Hitzler, M
    Chiba, P
    BIOCHEMICAL PHARMACOLOGY, 1999, 58 (09) : 1447 - 1456
  • [9] Structure-Activity Relationship Study of Permethyl Ningalin B Analogues as P-Glycoprotein Chemosensitizers
    Bin, Jin Wen
    Wong, Iris L. K.
    Hu, Xuesen
    Yu, Zhang Xiao
    Xing, Li Fu
    Jiang, Tao
    Chow, Larry M. C.
    Biao, Wan Sheng
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (22) : 9057 - 9070
  • [10] Hydrophobic moments as physicochemical descriptors in structure-activity relationship studies of P-glycoprotein inhibitors
    Gerhard König
    Peter Chiba
    Gerhard F. Ecker
    Monatshefte für Chemie - Chemical Monthly, 2008, 139 : 401 - 405